Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,814 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial glioma.
Patel MA, Kim JE, Theodros D, Tam A, Velarde E, Kochel CM, Francica B, Nirschl TR, Ghasemzadeh A, Mathios D, Harris-Bookman S, Jackson CC, Jackson C, Ye X, Tran PT, Tyler B, Coric V, Selby M, Brem H, Drake CG, Pardoll DM, Lim M. Patel MA, et al. Among authors: jackson c, jackson cc. J Immunother Cancer. 2016 May 17;4:28. doi: 10.1186/s40425-016-0132-2. eCollection 2016. J Immunother Cancer. 2016. PMID: 27190629 Free PMC article.
Erratum to: Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial glioma.
Patel MA, Kim JE, Theodros D, Tam A, Velarde E, Kochel CM, Francica B, Nirschl TR, Ghasemzadeh A, Mathios D, Harris-Bookman S, Jackson CC, Jackson C, Ye X, Tran PT, Tyler B, Coric V, Selby M, Brem H, Drake CG, Pardoll DM, Lim M. Patel MA, et al. Among authors: jackson c, jackson cc. J Immunother Cancer. 2016 Nov 4;4:74. doi: 10.1186/s40425-016-0181-6. eCollection 2016. J Immunother Cancer. 2016. PMID: 27822377 Free PMC article.
Bespoke immunotherapy: how close are we?
Jackson C, Lim M. Jackson C, et al. Neuro Oncol. 2019 Feb 19;21(3):289-290. doi: 10.1093/neuonc/noz017. Neuro Oncol. 2019. PMID: 31222359 Free PMC article. No abstract available.
Combination immunotherapy strategies for glioblastoma.
Chan HY, Choi J, Jackson C, Lim M. Chan HY, et al. Among authors: jackson c. J Neurooncol. 2021 Feb;151(3):375-391. doi: 10.1007/s11060-020-03481-0. Epub 2021 Feb 21. J Neurooncol. 2021. PMID: 33611705 Review.
Synergy between glutamate modulation and anti-programmed cell death protein 1 immunotherapy for glioblastoma.
Medikonda R, Choi J, Pant A, Saleh L, Routkevitch D, Tong L, Belcaid Z, Kim YH, Jackson CM, Jackson C, Mathios D, Xia Y, Shah PP, Patel K, Kim T, Srivastava S, Huq S, Ehresman J, Pennington Z, Tyler B, Brem H, Lim M. Medikonda R, et al. Among authors: jackson cm, jackson c. J Neurosurg. 2021 Aug 13;136(2):379-388. doi: 10.3171/2021.1.JNS202482. Print 2022 Feb 1. J Neurosurg. 2021. PMID: 34388730
Combination checkpoint therapy with anti-PD-1 and anti-BTLA results in a synergistic therapeutic effect against murine glioblastoma.
Choi J, Medikonda R, Saleh L, Kim T, Pant A, Srivastava S, Kim YH, Jackson C, Tong L, Routkevitch D, Jackson C, Mathios D, Zhao T, Cho H, Brem H, Lim M. Choi J, et al. Among authors: jackson c. Oncoimmunology. 2021 Aug 29;10(1):1956142. doi: 10.1080/2162402X.2021.1956142. eCollection 2021. Oncoimmunology. 2021. PMID: 34484870 Free PMC article.
4,814 results